Home/Filings/4/0000899243-20-028539
4//SEC Filing

GILL JOHN 4

Accession 0000899243-20-028539

CIK 0001326190other

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 7:00 PM ET

Size

7.3 KB

Accession

0000899243-20-028539

Insider Transaction Report

Form 4
Period: 2020-09-24
GILL JOHN
Director
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.0001

    2020-09-24+16,85019,624 total
  • Exercise/Conversion

    Restricted Stock Units ("RSUs")

    2020-09-2416,8500 total
    Common Stock (16,850 underlying)
Footnotes (2)
  • [F1]Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
  • [F2]On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020.

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1
  • filerCIK 0001409939

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 7:00 PM ET
Size
7.3 KB